Showing results (31-40 of 42) with videos related to
Sort By:
Pageof 5
Aging|September 8, 2020
HOXC10 promotes tumour metastasis by regulating the EMT-related gene Slug in ovarian cancerYulong Peng, Yuanyuan Li, Yimin Li, et al.Cell Death & Disease|November 4, 2020
Combined treatment of mitoxantrone sensitizes breast cancer cells to rapalogs through blocking eEF-2K-mediated activation of Akt and autophagyYidi Guan, Shilong Jiang, Wenling Ye, et al.Cancer Management and Research|June 18, 2020
SOX10 - A Novel Marker for the Differential Diagnosis of Breast Metaplastic Squamous Cell CarcinomaJialin Qi, Zhenmin Hu, Heng Xiao, et al.Acta Biochimica Et Biophysica Sinica|March 25, 2017
Resveratrol derivative BTM-0512 mitigates obesity by promoting beige remodeling of subcutaneous preadipocytesQingqing Li, Kuansong Wang, Yipeng Ma, et al.Oncotarget|June 9, 2016
Sirt3-mediated mitophagy protects tumor cells against apoptosis under hypoxiaAimin Qiao, Kuansong Wang, Yunsheng Yuan, et al.Oncotarget|March 20, 2018
Immunoclassification characterized by CD8 and PD-L1 expression is associated with the clinical outcome of gastric cancer patientsWeili Wang, Kuansong Wang, Zihua Chen, et al.Pharmacogenomics|July 4, 2020
High levels of tumor-infiltrating lymphocytes showed better clinical outcomes in FOLFOX-treated gastric cancer patientsWei Li, Weili Wang, Ping Liao, et al.Oncotarget|June 23, 2018
Correction: Sirt3-mediated mitophagy protects tumor cells against apoptosis under hypoxiaAimin Qiao, Kuansong Wang, Yunsheng Yuan, et al.Journal of Experimental & Clinical Cancer Research : CR|July 7, 2025
Single-cell transcriptome analysis reveals the malignant characteristics of tumour cells and the immunosuppressive landscape in HER2-positive inflammatory breast cancerJuan Huang, Yongwei Zhu, Wenjing Zeng, et al.International Journal of Surgery (London, England)|September 19, 2025
Efficacy and safety of neoadjuvant treatment of trastuzumab and pyrotinib plus dalpiciclib in HR-negative/HER2-positive breast cancer: an exploratory, open-label phase II studyZhi Xiao, Feiyu Chen, Liqiu Liao, et al.Pageof 5